Authors: Murphy, MP Beaman, ME Clark, LS Cayouette, M Benson, L Morris, DM Polli, JW

Citation: Mp. Murphy et al., Prospective CYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial (vol 10, pg 583, 2000), PHARMACOGEN, 11(2), 2001, pp. 185-185

Authors: Cayouette, M Whitmore, AV Jeffery, G Raff, M

Citation: M. Cayouette et al., Asymmetric segregation of numb in retinal development and the influence ofthe pigmented epithelium, J NEUROSC, 21(15), 2001, pp. 5643-5651

Authors: Murphy, MP Beaman, ME Clark, LS Cayouette, M Benson, L Morris, DM Polli, JW

Citation: Mp. Murphy et al., Prospective GYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial, PHARMACOGEN, 10(7), 2000, pp. 583-590

Authors: Cayouette, M Smith, SB Becerra, SP Gravel, C

Citation: M. Cayouette et al., Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations, NEUROBIOL D, 6(6), 1999, pp. 523-532